Abstract
BackgroundBiological therapy is a cornerstone of managing moderate-to-severe inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn’s disease (CD). New biologics have been evolving over the past 20 years and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have